von Kügelgen I, Kurz K, Starke K
Pharmakologisches Institut, Universität Freiburg, Federal Republic of Germany.
Neuroscience. 1993 Sep;56(2):263-7. doi: 10.1016/0306-4522(93)90330-i.
Extracellular ATP acts on P2-purinoceptors of peripheral effector cells, and this is the basis for its function as a (co-)transmitter in peripheral efferent neurons. ATP also acts on P2-receptors of neuronal cell bodies or dendrites, and this is the basis for its function as a fast excitatory transmitter at neuroneural synapses. A third site of action is axon terminals. In the vas deferens of the mouse, noradrenaline and ATP are postganglionic sympathetic co-transmitters, and exogenous ATP acts on P2-purinoceptors of the sympathetic terminals to inhibit release of noradrenaline. Here we show that two P2 antagonists, suramin and Reactive Blue 2, increase the release of noradrenaline in mouse vas deferens. The increase is only obtained when there has been preceding nerve activity and is largely independent of the postjunctional response. These findings indicate a physiological function for axon terminal P2-purinoceptors: they mediate a novel prejunctional negative feedback in which released ATP inhibits subsequent transmitter release.
细胞外ATP作用于外周效应细胞的P2嘌呤受体,这是其在外周传出神经元中作为(共)递质发挥功能的基础。ATP还作用于神经元细胞体或树突的P2受体,这是其在神经-神经突触中作为快速兴奋性递质发挥功能的基础。第三个作用位点是轴突终末。在小鼠输精管中,去甲肾上腺素和ATP是节后交感神经的共递质,外源性ATP作用于交感神经终末的P2嘌呤受体以抑制去甲肾上腺素的释放。在此我们表明,两种P2拮抗剂苏拉明和活性蓝2可增加小鼠输精管中去甲肾上腺素的释放。只有在先前存在神经活动时才会出现这种增加,并且在很大程度上与节后反应无关。这些发现表明轴突终末P2嘌呤受体具有生理功能:它们介导一种新的节前负反馈,即释放的ATP抑制随后的递质释放。